mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.003 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
0.007 |